Intelligent Bio Solutions (INBS) Shares Outstanding (Weighted Average) (2019 - 2025)
Intelligent Bio Solutions (INBS) recorded quarterly Shares Outstanding (Weighted Average) of $5.5 million in Q2 2025, up 854.36% quarter-over-quarter from $577191.0 in Q1 2025, and up 245.85% on a YoY basis from $1.6 million in Q2 2024.
Intelligent Bio Solutions (INBS) Shares Outstanding (Weighted Average) (2019 - 2025) Analysis & Trends
Intelligent Bio Solutions' Shares Outstanding (Weighted Average) history runs 7 years deep, the most recent figure standing at $5.5 million for Q2 2025.
- In Q2 2025, Shares Outstanding (Weighted Average) rose 245.85% year-over-year to $5.5 million; the TTM figure through Jun 2025 stood at $5.5 million (up 245.85% YoY), while the FY2025 annual figure was $5.5 million, up 245.85% from the prior year.
- Shares Outstanding (Weighted Average) was $5.5 million for Q2 2025 at Intelligent Bio Solutions, up from $577191.0 in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $14.9 million in Q3 2022 to a low of $75690.0 in Q4 2022.
- Historically, Shares Outstanding (Weighted Average) has averaged $3.2 million across 5 years, with a median of $731398.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Weighted Average) tumbled 98.7% in 2023, then soared 1862.46% in 2024.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $744126.0 in 2021, then slumped by 89.83% to $75690.0 in 2022, then soared by 655.62% to $571930.0 in 2023, then declined by 27.03% to $417345.0 in 2024, then surged by 1219.89% to $5.5 million in 2025.
- The last three Shares Outstanding (Weighted Average) figures came in at $5.5 million (Q2 2025), $577191.0 (Q1 2025), and $417345.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Intelligent Bio Solutions | 12.67 Mn | 11.47 Mn | - | 5.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 5.51 Mn |
| Mar 31, 2025 | 577,191.00 |
| Dec 31, 2024 | 417,345.00 |
| Sep 30, 2024 | 3.81 Mn |
| Jun 30, 2024 | 1.59 Mn |
| Mar 31, 2024 | 1.11 Mn |
| Dec 31, 2023 | 571,930.00 |
| Sep 30, 2023 | 194,200.00 |
| Jun 30, 2023 | 83,717.00 |
| Mar 31, 2023 | 76,629.00 |
| Dec 31, 2022 | 75,690.00 |
| Sep 30, 2022 | 14.89 Mn |
| Jun 30, 2022 | 733,263.00 |
| Mar 31, 2022 | 729,533.00 |
| Dec 31, 2021 | 744,126.00 |
| Sep 30, 2021 | 14.01 Mn |
| Jun 30, 2021 | 520,744.00 |
| Mar 31, 2021 | 11.80 Mn |
| Dec 31, 2020 | 8.62 Mn |
| Sep 30, 2020 | 8.63 Mn |